Differential impact of TIM-3 ligands on NK cell function
Background The transmembrane protein T-cell immunoglobulin and mucin-domain containing molecule 3 (TIM-3) is an immune checkpoint receptor that is expressed by a variety of leukocyte subsets, particularly in the tumor microenvironment. An effective TIM-3-targeting therapy should account for multiple...
Saved in:
Main Authors: | Xin Zhang, Lazar Vujanovic, Riyue Bao, Robert L Ferris, Tullia C Bruno, Aditi Kulkarni, Hridesh Banerjee, Housaiyin Li, Juncheng Wang, Lawrence P Kane, Pragati Upadhyay, Jennifer L Anderson, Onyedikachi Victor Onyekachi, Lidia M R B Arantes |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/13/1/e010618.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell Lymphoma
by: Tingting Zhang, et al.
Published: (2020-01-01) -
Discovery of PRMT5 N‑Terminal TIM Barrel Ligands from Machine-Learning-Based Virtual Screening
by: Zhihang Shen, et al.
Published: (2025-01-01) -
Selective Phenome Growth Adapted NK Model: A Novel Landscape to Represent Aptamer Ligand Binding
by: Andrew Brian Kinghorn, et al.
Published: (2017-01-01) -
Tim Dowley, Bibelatlas kompakt
by: S. J. P. K. Riekert
Published: (2006-12-01) -
Tim Burton — L’exposition
by: Clémence Simon
Published: (2012-10-01)